| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ceranib-2 | CTRPv2 | pan-cancer | AAC | -0.074 | 0.02 |
| mRNA | Dasatinib | CTRPv2 | pan-cancer | AAC | 0.081 | 0.02 |
| mRNA | YK 4-279 | CTRPv2 | pan-cancer | AAC | -0.072 | 0.02 |
| mRNA | phloretin | CTRPv2 | pan-cancer | AAC | -0.076 | 0.03 |
| mRNA | ciclosporin | CTRPv2 | pan-cancer | AAC | -0.083 | 0.03 |
| mRNA | alisertib | CTRPv2 | pan-cancer | AAC | -0.07 | 0.03 |
| mRNA | indisulam | CTRPv2 | pan-cancer | AAC | -0.071 | 0.03 |
| mRNA | tacrolimus | CTRPv2 | pan-cancer | AAC | -0.077 | 0.03 |
| mRNA | nakiterpiosin | CTRPv2 | pan-cancer | AAC | -0.072 | 0.03 |
| mRNA | procarbazine | CTRPv2 | pan-cancer | AAC | 0.086 | 0.03 |